Oramed Pharmaceuticals Inc. (ORMP)

Oramed Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Aug 31, 2012
Cash & Equivalents	45.95	54.42	9.06	40.46	4.43
Short-Term Investments	84.58	87.51	152.99	115.26	0.65
Cash & Short-Term Investments	130.53	141.93	162.05	155.72	5.09
Cash Growth	-8.03%	-12.41%	4.06%	2962.08%	87.18%
Other Receivables	-	-	-	-	0.17
Total Trade Receivables	-	-	-	-	0.17
Other Current Assets	2.74	1.29	0.54	1.39	2.32
Total Current Assets	133.27	143.22	162.58	157.11	5.28
Net Property, Plant & Equipment	1.34	1.11	1.57	1.8	0
Long-Term Investments	96.21	10.91	56.37	2.7	-
Other Long-Term Assets	0.05	0.03	0.03	0.03	0.01
Total Assets	230.86	155.28	220.55	161.64	5.29
Accounts Payable	6.85	5.47	1.93	4.16	0.64
Short-Term Debt	-	-	51.01	-	-
Current Portion of Leases	0.29	0.22	0.27	0.25	-
Unearned Revenue	1.35	-	-	1.34	-
Other Current Liabilities	10.6	-	-	-	-
Total Current Liabilities	19.09	5.69	53.21	5.75	0.64
Long-Term Leases	0.54	0.16	0.34	0.65	-
Other Long-Term Liabilities	11.49	4.09	4.1	4.09	0.87
Total Long-Term Liabilities	12.03	4.25	4.44	4.74	0.87
Total Liabilities	31.12	9.93	57.66	10.49	1.52
Common Stock	0.47	0.48	0.49	0.48	0.08
Additional Paid-in Capital	322.71	322.4	320.89	314.42	21.59
Retained Earnings	-123.44	-176.62	-157.56	-163.08	-17.89
Total Common Shareholders' Equity	199.74	146.27	163.82	151.81	3.78
Minority Interest	-	-0.92	-0.93	-0.66	-
Shareholders' Equity	199.74	145.35	162.89	151.16	3.78
Total Liabilities & Equity	230.86	155.28	220.55	161.64	5.29
Total Debt	0.83	0.37	51.62	0.89	0
Net Cash (Debt)	129.71	141.56	110.43	154.83	5.09
Net Cash Growth	-8.37%	28.19%	-28.68%	2944.50%	87.18%
Net Cash Per Share	3.06	3.46	2.72	3.97	0.86
Book Value	199.74	146.27	163.82	151.81	3.78
Book Value Per Share	4.71	3.58	4.04	3.89	0.64
Tangible Book Value	199.74	146.27	163.82	151.81	3.78
Tangible Book Value Per Share	4.71	3.58	4.04	3.89	0.64

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q